ACKNOWLEDGMENTS
ONCOLOGY
This study was sponsored by Sierra Oncology, a GSK company. Lynn Neilson, a medical writer employed by Sierra Oncology, provided editorial assistance to the authors during preparation of this manuscript. Additional editorial support was provided by Second City Science, which was funded by Sierra Oncology in accordance with Good Publications Practice 3 (GPP3) guidelines.